Spots Global Cancer Trial Database for Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Official Title: Clinical and Biologic Effects of Metformin in Early Stage Breast Cancer
Study ID: NCT00897884
Conditions
Interventions
Study Description
Brief Summary: The study will be testing metformin in patients with breast cancer who are about to undergo surgery. Patients will take metformin 3 times daily for about 2-3 weeks prior to their surgery date. It is hypothesized that metformin will reduce cell proliferation rates in tumour tissue.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Mount Sinai Hospital, Toronto, Ontario, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
Contact Details
Name: Pamela J Goodwin, MD
Affiliation: MOUNT SINAI HOSPITAL
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
